Zydus Lifesciences Limited

ZYDUSLIFE.NS·NSE·Healthcare
Compare
1,193.00+4.90 (+0.41%)today
At close: Nov 5, 3:28 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,188.10
Open1,200.00
Day range1,172.001,204.90
52-week range835.501,266.60
Off day high−0.99%
Off 52-week high−5.81%
Volume2.31M
Avg. volume (3M)1.63M
Market cap1.19T
EPS (TTM)41.85
Forward P/E23.91
P/E ratio (TTM)28.51
Dividend yield0.08% (1.00)
Beta (5Y)0.31
Shares outstanding997.50M
Short interest—
Earnings dateNov 4, 2026
Analyst target1,220.98
Profit margin15.78%

Against its peers

Compare in full ›
ZYDUSLIFE.NS ERIS.NS 0QFP.IL MEGA.BK 0MTD.IL FDC.BO
Market cap 1.19T 170.63B 4.46T 30.95B 177.20B 63.76B
P/E (TTM) 28.5 23.9 18.8 14.2 50.3 20.4
Forward P/E 23.9 22.0 — 12.4 — 30.1
Price/book 4.3 4.1 2.1 3.0 5.1 2.4
Dividend yield 0.08% 1.19% 7.74% 4.86% — 2.56%
1-year change +26.84% −23.36% 0.00% +20.69% +46.92% −7.27%
Today +0.41% +1.23% +156.25% +1.43% +1.51% +0.13%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

BusinessLine·Positive

Q2 Results 04th Nov Live: BSE, Cummins, Zydus Lifesciences, Apollo, Lenskart, Nykaa, Aurobindo Pharma, NHPC, Dabur, Torrent Power, Biocon, Sundaram Finance, Premier Energies, Physicswallah Share to announce Q2 results, Bajaj Finserv, SBI, NSE, Lupin shares in focus

Follow our stock market live updates here | Stay tuned to businessline for more. GAINERS: SBI, Emcure Pharma, Awfis Space Sensex gained 214.75 pts or 0.28% to 77,132.60 at 9.16 am after opening at 76,853.11 from 76,917.85 previous close.…

Kalkine India·Negative

Zydus Lifesciences Q2 FY27 Results: Key Figures Disclosed

Kalkine India Zydus Lifesciences (NSE:ZYDUSLIFE): What Did Q2 FY27 Results Reveal? Source: Krish Capital Pty Ltd Zydus Lifesciences (NSE:ZYDUSLIFE) disclosed its unaudited standalone and consolidated financial results for the quarter and…

Business Upturn·Positive

Zydus Lifesciences receives ESG rating of 71 for 2026

Zydus Lifesciences Limited has been assigned an overall Environmental, Social, and Governance (ESG) rating of 71 for the financial year 2026. This rating places the company in the 'leader' category, as per the assessment conducted by NSE…

From the 4Search news index, newest first.

In the news

31mentions in 30 days
31with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 31 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance